← Back to Search

Biofeedback Training for Hemianopia

N/A
Recruiting
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18-90 years old
Ability to follow the visual and auditory stimuli and training instructions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week post biofeedback
Awards & highlights

Study Summary

This trial is testing a new eye movement training therapy for people who have lost vision in one side of their field of view due to stroke, surgery, or trauma. The therapy uses biofeedback to help people learn to shift their eyes and bring information from the blind side into the seeing side.

Who is the study for?
This trial is for individuals aged 18-90 with hemianopia, a type of vision loss after brain injury from stroke, surgery, or trauma. Participants must be able to follow visual and auditory instructions but haven't had low vision rehabilitation before.Check my eligibility
What is being tested?
The study tests biofeedback training (BT) as a new technique for improving eye movement control in people with hemianopia. It aims to help patients adapt by learning to shift their gaze into the blind field of vision.See study design
What are the potential side effects?
Biofeedback training is generally considered safe; however, potential side effects are not detailed in this summary. Typically, BT might cause fatigue or discomfort due to intense concentration during sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 90 years old.
Select...
I can see, hear, and follow instructions well.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week post biofeedback
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week post biofeedback for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fixation stability
Near vision
Quality of Life Questionnaire scores
+3 more
Secondary outcome measures
Contrast Sensitivity
Stereopsis

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group AExperimental Treatment1 Intervention
The patients will undergo baseline assessment and receive the intervention, being assessed after the intervention.
Group II: Group BActive Control1 Intervention
The patients will perform the same tests for assessment as in group A, however, no intervention will be done. They may enrol in the study as group B after completing group B participation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biofeedback training
2013
N/A
~400

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,463 Previous Clinical Trials
483,502 Total Patients Enrolled
University of TorontoOTHER
687 Previous Clinical Trials
1,018,338 Total Patients Enrolled

Media Library

Biofeedback training Clinical Trial Eligibility Overview. Trial Name: NCT05397873 — N/A
Homonymous Hemianopia Research Study Groups: Group B, Group A
Homonymous Hemianopia Clinical Trial 2023: Biofeedback training Highlights & Side Effects. Trial Name: NCT05397873 — N/A
Biofeedback training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05397873 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the age of 40 represent a cutoff for participation in this medical study?

"The qualifications for participation in this trial require candidates to be at least 18 years of age and not surpass the age of 90. For those below 18, there are 179 studies available while 1557 can be found for seniors over 65."

Answered by AI

Is eligibility for this experiment open to the public?

"A maximum of 32 participants can join this clinical trial, and all must be 18 years old or above and have had a stroke."

Answered by AI

Are there any availability for participation in this study right now?

"The clinical trial database reveals that this project is currently looking for individuals to enrol. This research endeavour was initially published on July 8th 2021 and edited most recently on May 24th 2022."

Answered by AI

How many participants are involved in this medical investigation?

"Affirmative. Clinicaltrials.gov has confirmed that this clinical trial is actively seeking participants, with the original post being dated July 8th 2021 and last edited on May 24th 2022. The study requires 32 patients to be enrolled from one site."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
~9 spots leftby Mar 2025